FindTrial
Sign In

Real world study of P16 probiotic solid beverage in adjuvant treatment of patients with chronic constipation

Real world study of P16 probiotic solid beverage in adjuvant treatment of patients with chronic constipation

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200056560
Enrollment
Unknown
Registered
2022-02-08
Start date
2022-02-08
Completion date
Unknown
Last updated
2024-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

chronic constipation

Interventions

Case series:None

Sponsors

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient is consuming P16 probiotic solid drink; 2. Patients voluntarily participated, gave informed consent and joined the patient follow-up platform set up by Shanghai Mace Medical Technology Co., LTD.; 3. The patient has chronic gastrointestinal symptoms, such as chronic constipation, dyspepsia and abdominal distension.

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
Symptoms of patients with chronic constipation were relieved;—

Secondary

MeasureTime frame
Relieving effect on chronic gastrointestinal symptoms and functional gastrointestinal diseases;Positive effect on patients' anxiety, depression and quality of life;—

Countries

China

Contacts

Public ContactHou Xiaohua

Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology

houxh@hust.edu.cn+86 13035143646

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026